Meteora Capital’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History
Bought
Maintained
Sold
Other funds holding TDACW
Meteora Capital's TDACW Position: Q2 2026 in Review
Meteora Capital sold out of Translational Development Acquisition Corp Warrants (TDACW) in Q2 2026, closing a stake of 189,507 shares — an estimated $22.8K sold.
Meteora Capital first reported a position in TDACW in Q3 2025 and held it in 3 quarters. The position peaked at $60.3K in Q4 2025. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.
- Meteora Capital reported no remaining Translational Development Acquisition Corp Warrants position as of Q2 2026 after selling out during the quarter.
- Meteora Capital sold 189,507 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $22.8K.
- Meteora Capital first reported a position in Translational Development Acquisition Corp Warrants in Q3 2025 and held it in 3 quarters.
- Meteora Capital's Translational Development Acquisition Corp Warrants position peaked at $60.3K in Q4 2025.
- 28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.
Based on Meteora Capital's 13F filing for Q2 2026, filed 14 Aug 2026.